Seattle, WA, United States of America

Kenneth B Lewis

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2004-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Kenneth B Lewis

Introduction

Kenneth B Lewis is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the development of methods and systems for antibody response phenotyping and tissue sealant compositions. With a total of 2 patents, his work has had a meaningful impact on medical research and applications.

Latest Patents

Lewis's latest patents include innovative technologies that enhance our understanding of immune responses. One of his patents focuses on "Antibody response phenotyping," which discloses methods, systems, mediums, and kits for phenotyping antibody responses using devices such as surface plasmon resonance devices. This technology allows for the assessment of total target-specific antibody titers, quantitative isotype distribution, and epitope specificity of target-specific antibodies. Another significant patent is for "Tissue sealant compositions," which includes formulations containing human recombinant fibrinogen, human recombinant factor XIII, and human recombinant thrombin. These compositions are designed for use in various medical applications, showcasing Lewis's commitment to advancing healthcare solutions.

Career Highlights

Throughout his career, Kenneth B Lewis has worked with reputable companies such as Zymogenetics, Inc. and Bloodworks. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Paul A Brown and Gerald W Lasser. Their collective expertise has likely fostered an environment of innovation and creativity, leading to the successful development of new technologies.

Conclusion

Kenneth B Lewis is a distinguished inventor whose work in antibody response phenotyping and tissue sealant compositions has made a significant impact in the field of biotechnology. His contributions continue to influence medical research and applications, highlighting the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…